MHC class II-expressing thymocytes suppress invariant NKT cell development

Immunology and Cell Biology

Volumn 87, Issue 2, 2009, Pages 186-189

  Li, Wei ^a   Sofi, M Hanief ^b   Wei, Datsen G ^c   Du, Wenjun ^d   Gervay Hague, Jacquelyn ^d   Renukaradhya, Gourapura J ^a   Brutkiewicz, Randy R ^a   Chang, Cheong Hee ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD1d; iNKT cells; MHC class II; Thymocyte development; Transgenic mice

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD4 ANTIGEN; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL COUNT; CELL MATURATION; CELL SELECTION; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; IN VIVO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OBSERVATIONAL STUDY; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; NUCLEAR PROTEINS; THYMUS GLAND; TRANS-ACTIVATORS;

MUS MUSCULUS;

EID: 60749129178     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.78     Document Type: Article

References (22)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
2. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877-900.
3. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007; 7: 505-518.
4. Gapin L, Matsuda JL, Surh, CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2001; 2: 971-978.
5. Pellicci DG, Uldrich AP, Kyparissoudis K, Crowe NY, Brooks AG, Hammond KJ et al. Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur J Immunol 2003; 33: 1816-1823.
6. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, Nguyen H et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 2003; 197: 907-918.
7. Bendelac A, Killeen N, Littman DR, Schwartz RH. A subset of CD4+ thymocytes selected by MHC class I molecules. Science 1994; 263: 1774-1778.
8. Voyle RB, Beermann F, Lees RK, Schumann J, Zimmer J, Held W et al. Liganddependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J Exp Med 2003; 197: 919-925.
9. Schumann J, Pittoni P, Tonti E, Macdonald HR, Dellabona P, Casorati G. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells. J Immunol 2005; 175: 7303-7310.
10. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999; 163: 2314-2321.
11. Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci USA 2001; 98: 3294-3298.
12. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 2002; 195: 637-641.
13. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123: 1031-1043.
14. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002; 195: 625-636.
15. Li W, Kim MG, Gourley TS, McCarthy BP, Sant'angelo DB, Chang CH. An alternate pathway for CD4T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 2005; 23: 375-386.
16. Patel DR, Li W, Park JS, Sofi MH, Gourley TS, Hangoc G et al. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus. Cell Immunol 2005; 233: 30-40.
17. Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181: 765-767.
18. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001; 15: 897-908.
19. Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C et al. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood 2007; 110: 251-258.
20. Chen X, Wang X, Besra GS, Gumperz JE. Modulation of CD1d-restricted NKT cell responses by CD4. J Leukoc Biol 2007; 82: 1455-1465.
21. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997; 6: 469-477.
22. Du W, Kulkarni SS, Gervay-Hague J. Efficient, one-pot syntheses of biologically active alpha-linked glycolipids. Chem Commun (Camb) 2007; 23: 2336-2338.